安捷伦新GMP就绪xCELLigence软件如何重塑安捷伦科技(A)投资者前景 - Sahm
How Agilent’s New GMP-Ready xCELLigence Software Could Reshape Agilent Technologies (A) Investors’ Outlook - Sahm
生物技术与制药领域的最新动态
How Agilent’s New GMP-Ready xCELLigence Software Could Reshape Agilent Technologies (A) Investors’ Outlook - Sahm
Milestone finally wins FDA approval for arrythmia nasal spray
Early changes in the properties of CA3 engram cells explored with a novel viral tool in mice
Chromatin accessibility variation provides insights into missing regulation underlying immune-mediated diseases
Dissociable memory modulation mechanisms facilitate fear amnesia at different timescales
IL-27 limits HSPC differentiation during infection and protects from stem cell exhaustion
Sobi snaps up gout drug in $950M deal for startup Arthrosi
Illumina’s AI Genomics Partnership With MyOme Might Change The Case For Investing In Illumina (ILMN) - simplywall.st
Thrivent Financial for Lutherans Sells 75,008 Shares of Waters Corporation $WAT - MarketBeat
Waters Corporation $WAT Holdings Cut by London Co. of Virginia - MarketBeat
MASTERINVEST Kapitalanlage GmbH Purchases Shares of 15,293 Agilent Technologies, Inc. $A - MarketBeat
Humankind Investments LLC Purchases 1,772 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Liontrust Investment Partners LLP Has $95.53 Million Position in Agilent Technologies, Inc. $A - MarketBeat
10x Genomics $TXG Position Increased by Nikko Asset Management Americas Inc. - MarketBeat
Nikko Asset Management Americas Inc. Increases Stake in Illumina, Inc. $ILMN - MarketBeat
Headlands Technologies LLC Has $5.42 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Taking Stock of Thermo Fisher Scientific (TMO) Valuation After Analyst Upgrades and Bioprocessing, Cardio Testing Moves - Yahoo Finance
How New Genomics Partnership And Asian Bioprocessing Push At Thermo Fisher Scientific (TMO) Has Changed Its Investment Story - simplywall.st
Why The Narrative Around 10x Genomics Is Shifting After New Institutional Buying And Product Updates - Yahoo Finance
Eli Lilly’s triple-G obesity readout; The latest Endpoints 100 results; Public biotechs cash in; and more